Filing Details

Accession Number:
0001209191-17-021691
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-20 16:05:47
Reporting Period:
2017-03-16
Filing Date:
2017-03-20
Accepted Time:
2017-03-20 16:05:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293971 Bluebird Bio Inc. BLUE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1177082 Daniel Lynch C/O Bluebird Bio, Inc.
150 Second Street
Cambridge MA 02141
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-16 237 $2.09 1,637 No 4 M Direct
Common Stock Disposition 2017-03-16 237 $100.07 1,400 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-03-16 237 $0.00 237 $2.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,271 2021-07-13 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2016.
  2. The range of prices for the transaction reported on this line was $100.00 to $100.40. The average weighted price was $100.0743. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. This option vests over a four-year period in 48 equal monthly installments beginning on April 15, 2011